No insider purchase over the last 90 days. The latest, by 제넥신, was filed 05 Jun 2026.
NeoImmuneTech, Inc.: what insiders have been doing
NeoImmuneTech, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). In the past year (22 October 2025 to 22 October 2026), 7 filings came from 5 insiders.
Open-market activity splits into 2 purchases and 4 sales; 2 insiders sit on the buying side and 4 insiders on the selling side. The totals do not cover 6 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 major shareholder and 1 chief executive among the declarants.
Compared with its exchange (2,650 companies, median 7 filings), a count of 7 filings is typical. Looking back to 2021, when coverage begins, insiders filed 4 purchases and 28 sales.
The latest purchase dates back some time: it was published 158 days ago, on 5 June 2026. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
In the same sector, recent insider purchases at UCB also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -32.7%Entry ₩2,505 · Close 21 Oct 2026 ₩1,687
- -32.7%Entry ₩2,505 · Close 21 Oct 2026 ₩1,687
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 104,856 sharesShareKRXDART:20260710000447
- 22,298,915 sharesShareKRXDART:20260710000537
- 140,065 sharesShareKRXDART:20260710000450
- 110,450 sharesShareKRXDART:20260710000454
- 1,427,900 sharesKRXDART:20260605000200Canonical exit: 3 Sept 2026 (T+90)
- 131,070 sharesShareKRXDART:20260514000056Canonical exit: 11 Aug 2026 (T+90)
- ●Executives0DART
- 50,000 sharesShareKRXDART:20250110000617
- 7,547,165 sharesKRXDART:20241004000263Canonical exit: 29 Dec 2024 (T+90)
- 972,677 sharesKRXDART:20240802000284
- 1,214,430 sharesKRXDART:20240405003050Canonical exit: 27 Jun 2024 (T+90)
- 2,920,480 sharesKRXDART:20240405002985
- ShareKRXDART:20231117000059
- 972,677 sharesKRXDART:20231103000242
- ShareKRXDART:20230718000060
- ShareKRXDART:20230626000226
- 972,677 sharesKRXDART:20230608000289
- ShareKRXDART:20230322000071
- 972,677 sharesKRXDART:20230309000511
- ShareKRXDART:20221207000035
- 972,677 sharesKRXDART:20221011000401
- ShareKRXDART:20221011000366
- ShareKRXDART:20221011000363
- ShareKRXDART:20221011000359
25 of 53 declarations
About NeoImmuneTech, Inc.
네오이뮨텍 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.
